Patients receiving OZEMPIC in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia
"The Dual Glucose-Dependent Insulinotropic Peptide and Glucagon-Like Peptide-1 Receptor Agonist, Tirzepatide, Improves Lipoprotein Biomarkers Associated with Insulin Resistance and Cardiovascular Risk in Patients with Type 2 Diabetes." Diabetes, Obesity and Metabolism, vol
Semaglutide is a medication originally developed to manage type 2 diabetes but is now widely used for weight loss
Water-rich foods: Cucumbers, watermelon, strawberries, lettuce, celery, oranges, and tomatoes all contribute significantly to daily fluid intake
doi:10.1161/HYPERTENSIONAHA.125.26055
In practice, these differences are usually minor and fall within the range of individual variation, but they add a layer of uncertainty that pharmaceutical products do not have